Mediclinic International (Mediclinic International) Interest Expense : $-85 Mil (TTM As of Sep. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Mediclinic International's interest expense for the six months ended in Sep. 2022 was $ -44 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2022 was $-85 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Mediclinic International's Operating Income for the six months ended in Sep. 2022 was $ 135 Mil. Mediclinic International's Interest Expense for the six months ended in Sep. 2022 was $ -44 Mil. Mediclinic International's Interest Coverage for the quarter that ended in Sep. 2022 was 3.05. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mediclinic International Interest Expense Historical Data

The historical data trend for Mediclinic International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediclinic International Interest Expense Chart

Mediclinic International Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Interest Expense

Get a 7-Day Free Trial

-85.20

-72.46

-97.77

-87.38

-83.00

Mediclinic International Semi-Annual Data
	Mar13	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22
Interest Expense	Get a 7-Day Free Trial															-45.34	-38.84	-43.96	-40.84	-44.17

Mediclinic International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-85 Mil.

Mediclinic International (OTCPK:ANHGY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mediclinic International's Interest Expense for the six months ended in Sep. 2022 was $-44 Mil. Its Operating Income for the six months ended in Sep. 2022 was $135 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2022 was $2,867 Mil.

Mediclinic International's Interest Coverage for the quarter that ended in Sep. 2022 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2022 )	/	Interest Expense (Q: Sep. 2022 )
	=	-1	*	134.768	/	-44.168
	=	3.05

The higher the ratio, the stronger the company's financial strength is.

Mediclinic International (Mediclinic International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.mediclinic.com

Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.